Catalyst

Slingshot members are tracking this event:

Ultragenyx's rhGUS Phase 3 Data for Patients with MPS7 Due Mid 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RARE

100%

Additional Information

Clinical Data Ultragenyx announced in a press release it will be releasing data for it's MPS7 drug rhGUS mid 2016.
http://ir.ultragenyx...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 14, 2016
Occurred Source:
Related Keywords Mps7, Rhgus, Phase 3 Data